1-(5-isoquinolinesulfonyl)homopiperazine,
AT 877,
AT-877,
AT877,
fasudil,
fasudil hydrochloride,
fasudil mesylate,
HA 1077,
HA-1077,
203911-27-7,
Fasudil dihydrochloride,
103745-39-7,
HA-1077 DIHYDROCHLORIDE,
5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline dihydrochloride,
ha-1077,
HA 1077, Dihydrochloride,
(5-Isoquinolinesulfonyl)homopiperazine, 2HCl,
(5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE,2HCL,
Q-101028,
Q-201107,
1-(5-Isoquinolinylsulfonyl)homopiperazine dihydrochloride,
MFCD00153805,
MFCD00866182,
1-(5-ISOQUINOLINE-SULFONYL)-HOMOPIPERAZINE,
SCHEMBL599053,
CTK8B3961,
BIH1037,
EX-A060,
ZX-AFC000064,
HMS3229O06,
Fasudil (HA-1077) hydrochloride,
ANW-43554,
IN1296,
AKOS005146464,
CCG-206851,
EBD2185037,
RTC-020891,
SF-0577,
SC-22700,
TC-020891,
FT-0080102,
SR-00000000577,
HA-1077 dihydrochloride, solid, >=98% (HPLC),
J-001032,
SR-00000000577-1,
5-(1,4-diazepan-1-ylsulfonyl)isoquinoline dihydrochloride,
Isoquinoline, 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-, hydrochloride (1:2),
Fasudil,
Fasudilum,
Fasudil HCl,
Fasudil hydrochloride,
Fasudil [INN],
Fasudilum [INN-Latin],
UNII-Q0CH43PGXS,
AT 877,
AT-877,
C14-H17-N3-O2-S,
HA1077,
HA 1077,
1-(5-Isoquinolinesulfonyl)homopiperazine,
A13785,
Fasudil dihydrochloride, 99% - 100MG 100mg,
Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine,
5-[(Hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline,
105628-07-7,